AZoLifeSciences on MSN
Molecular Test Targets Three Significant Pathogenic Fungi
This innovative assay detects key fungal pathogens with 100% accuracy, addressing urgent diagnostic needs for infections affecting immunocompromised patients.
Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately than traditional testing methods.
Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil ...
Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil ...
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic ...
Major market opportunities in blood group typing include advancements in PCR and NGS technologies, growing demand for personalized medicine, and increased healthcare access in emerging economies.
Researchers present a molecular test that can identify previously missed cases of Lyme disease and allows for faster diagnosis ...
The company aims to bring its technology — a lab-free detection method for cancers, viruses, and bacteria — to market in 2026 ...
Traditional bisulfite sequencing damages DNA, while enzyme-based alternatives are inconsistent. A novel methylation analysis ...
Abstract: This paper addresses the vulnerability of Global Navigation Satellite Systems (GNSS) to spoofing signal attacks by proposing a spoofing detection method based on multi-parameter features and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results